
Forte Biosciences, Inc.
Forte Biosciences, Inc.(FBRX)股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
fbrx · 股价预测 · 6 位分析师(近3月)· FMP · 更新于 2026年6月9日
分析师评级与共识
基于过去 3 个月内 6 位华尔街分析师
Buy
6 位分析师
共识
评级分布
12 个月目标价
High
$65.00
Consensus
$65.00
+311.7% upside
Low
$65.00
Median: $65 · Last Close: $15.79
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
Low Activity算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $15.00 | ↓ 5.00% |
1-day model range: $14.67–$15.34. Peak: $15.34 (-5.00%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | — | -34.0% |
| 2028 | — | -45.2% |
| 2029 | — | -49.9% |
| 2030 | — | -52.0% |
| 2031 | — | -53.1% |
基于技术分析的股价预测
14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · FBRX · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-11-17 | Chardan Capital | Maintains | Buy→Buy |
| 2025-08-15 | Chardan Capital | Maintains | Buy→Buy |
| 2025-06-24 | Chardan Capital | Maintains | Buy→Buy |
| 2025-04-01 | Chardan Capital | Maintains | Buy→Buy |
| 2024-12-04 | Chardan Capital | Maintains | Buy→Buy |
| 2024-11-15 | Chardan Capital | Maintains | Buy→Buy |
| 2024-08-19 | Chardan Capital | Maintains | Buy→Buy |
| 2024-04-08 | Ladenburg Thalmann | Upgrade ↑ | Neutral→Buy |
| 2021-09-20 | Chardan Capital | Upgrade ↑ | Sell→Neutral |
| 2021-09-03 | Brookline Capital | Downgrade ↓ | Buy→Hold |
Wall Street analysts have recently issued updated ratings on Forte Biosciences, Inc. (FBRX) stock. Of the recent 23 rating actions, 3 were upgrades and 5 were downgrades. 6 analysts currently cover FBRX.
分析师推荐趋势
FBRX analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测:EPS 与营收一致预期
Revenue This Year
$9M
↓ 37.1% YoY
Revenue Next Year
$23M
↑ 150.0% YoY
EPS This Year
$-4.11
EPS Next Year
$-4.25
↑ 3.6% YoY
EPS ForecastReported vs Estimated
Analysts forecast FBRX EPS of $-4.11 for the current fiscal year, based on estimates from 4 analysts. The FBRX revenue forecast is $9M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
FBRX 股价预测由两类独立数据源支撑:来自 6 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。FBRX 的共识目标价为 $65.00(+311.7% 上行空间),分析师共识为 Buy。
FBRX 的短期预测(明日)为 $15.00(-5.00%)。 FBRX 对 2030 年的预测区间为 $7–$8。
Forte Biosciences, Inc. 在 NASDAQ 上市,代码 FBRX。FBRX 在 2027 年的整体展望偏积极,在覆盖分析师中约 50% 对应 Buy 共识。
常见问题
FBRX 预测 · 8 个问题根据 6 位华尔街分析师,FBRX 的 12 个月平均目标价为 $65.00,最高 $65.00、最低 $65.00。若有图表,中位目标价可在上方查看。相对当前价 $15.79,隐含约 +311.7% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.